Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04649294 |
Other study ID # |
0052-17 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
June 1, 2017 |
Est. completion date |
December 20, 2018 |
Study information
Verified date |
October 2020 |
Source |
Hillel Yaffe Medical Center |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Long term steroid exposure, as in Cushing's disease, causes myocardial dysfunction,
hypertrophy and fibrosis in addition to causing obesity, hypertension and glucose
intolerance. The aim of our study was to verify if short-term high-dose exogenous steroid
therapy adversely effects the heart.
Description:
Patients eligible for high dose steroid therapy due to inflammatory diseases were offered to
participate in this study. The minimal total intravenous dose was 375 mg prednisone, and the
daily steroids were divided into 2-3 doses. To determine the steroids' effect on myocardial
function the echocardiographic studies included estimation of global and segmental
longitudinal strain. Each patient had a baseline echocardiographic study performed before
high-dose steroid therapy was initiated and again immediately after it. A follow-up echo
study was performed after completion of a 3-month low-dose steroid therapy period. The paired
2-tailed t-test was used to compare group means